Key regions: United Kingdom, South Korea, Europe, Japan, Germany
The Cold & Cough Remedies (Pharmacies) market in Central Africa is experiencing steady growth due to a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in Central Africa play a significant role in driving the growth of the Cold & Cough Remedies market. As more people become aware of the importance of maintaining good health, there is an increasing demand for over-the-counter remedies to alleviate symptoms of cold and cough. Customers in Central Africa often prefer purchasing these remedies from pharmacies due to the convenience and accessibility they offer. Trends in the market also contribute to the development of the Cold & Cough Remedies market in Central Africa. One notable trend is the increasing availability of a wide range of cold and cough remedies in pharmacies. This trend is driven by the growing number of pharmaceutical companies entering the market and the development of new and innovative products. As a result, customers have more options to choose from, leading to increased sales and market growth. Local special circumstances in Central Africa further contribute to the development of the Cold & Cough Remedies market. The region experiences a high prevalence of respiratory infections, including cold and cough, due to various factors such as climate, environmental conditions, and lifestyle. This creates a constant demand for remedies to alleviate symptoms and improve overall health. Additionally, the lack of access to healthcare facilities in some areas makes pharmacies the primary source of healthcare for many individuals, further driving the demand for cold and cough remedies. Underlying macroeconomic factors also play a role in the development of the Cold & Cough Remedies market in Central Africa. The region has been experiencing steady economic growth, which has led to an increase in disposable income and improved living standards. As a result, more people are able to afford healthcare products, including cold and cough remedies. Furthermore, the expansion of the pharmaceutical industry in Central Africa has created employment opportunities and contributed to overall economic development, further fueling the growth of the market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Central Africa is developing due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The increasing awareness of the importance of maintaining good health, the availability of a wide range of remedies, the high prevalence of respiratory infections, and the region's steady economic growth all contribute to the growth of the market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
